Photo by nci from unsplash
Subcutaneous implantable defibrillators (S-ICD) are attractive for preventing sudden cardiac death in patients with hypertrophic cardiomyopathy (HCM) as they mitigate risks of transvenous leads, although they may increase the risk… Click to show full abstract
Subcutaneous implantable defibrillators (S-ICD) are attractive for preventing sudden cardiac death in patients with hypertrophic cardiomyopathy (HCM) as they mitigate risks of transvenous leads, although they may increase the risk of inappropriate shock (IAS). We retrospectively collected data on
Keywords:
implantable defibrillators;
subcutaneous implantable;
hypertrophic cardiomyopathy;
inappropriate shock;
incidence determinants
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!